Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP284128.RA9ZX2k9-vyLmEZk0FxlKfrBLx70AbMUXT62dc4tZDjIo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP284128.RA9ZX2k9-vyLmEZk0FxlKfrBLx70AbMUXT62dc4tZDjIo130_assertion type Assertion NP284128.RA9ZX2k9-vyLmEZk0FxlKfrBLx70AbMUXT62dc4tZDjIo130_head.
- NP284128.RA9ZX2k9-vyLmEZk0FxlKfrBLx70AbMUXT62dc4tZDjIo130_assertion description "[RAR-beta2 expression was studied by reverse transcription-polymerase chain reaction (RT-PCR) analysis in eight breast cancer cell lines that were either treated with the demethylating agent 5-aza-2'-deoxycytidine and subsequently with all-trans-retinoic acid (ATRA) or left untreated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP284128.RA9ZX2k9-vyLmEZk0FxlKfrBLx70AbMUXT62dc4tZDjIo130_provenance.
- NP284128.RA9ZX2k9-vyLmEZk0FxlKfrBLx70AbMUXT62dc4tZDjIo130_assertion evidence source_evidence_literature NP284128.RA9ZX2k9-vyLmEZk0FxlKfrBLx70AbMUXT62dc4tZDjIo130_provenance.
- NP284128.RA9ZX2k9-vyLmEZk0FxlKfrBLx70AbMUXT62dc4tZDjIo130_assertion SIO_000772 10814678 NP284128.RA9ZX2k9-vyLmEZk0FxlKfrBLx70AbMUXT62dc4tZDjIo130_provenance.
- NP284128.RA9ZX2k9-vyLmEZk0FxlKfrBLx70AbMUXT62dc4tZDjIo130_assertion wasDerivedFrom befree-2016 NP284128.RA9ZX2k9-vyLmEZk0FxlKfrBLx70AbMUXT62dc4tZDjIo130_provenance.
- NP284128.RA9ZX2k9-vyLmEZk0FxlKfrBLx70AbMUXT62dc4tZDjIo130_assertion wasGeneratedBy ECO_0000203 NP284128.RA9ZX2k9-vyLmEZk0FxlKfrBLx70AbMUXT62dc4tZDjIo130_provenance.